Comparative effects of antiglaucoma drugs on voltage-dependent calcium channels

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 239, Issue 7, 2001, Pages 522-530

  Melena, José ^a   Stanton, David ^a   Osborne, Neville N ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; ALPHA 2 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; ANTIGLAUCOMA AGENT; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETAXOLOL; BRIMONIDINE; CALCIUM 45; CALCIUM CHANNEL; CALCIUM CHANNEL AFFECTING AGENT; CALCIUM CHANNEL L TYPE; CALCIUM CHANNEL N TYPE; CALCIUM CHANNEL P TYPE; CALCIUM CHANNEL Q TYPE; CALCIUM CHLORIDE; CALCIUM ION; CARBONATE DEHYDRATASE INHIBITOR; CARTEOLOL; DORZOLAMIDE; EDETIC ACID; GLUTAMATE RECEPTOR; GLUTAMIC ACID; KAINIC ACID; LATANOPROST; LEVOBUNOLOL; N METHYL DEXTRO ASPARTIC ACID; NEUROTRANSMITTER; PILOCARPINE; PROSTAGLANDIN DERIVATIVE; RADIOLIGAND; SODIUM CHLORIDE; TIMOLOL; UNINDEXED DRUG;

ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BRAIN CORTEX; BRAIN HOMOGENATE; CALCIUM TRANSPORT; COMPARATIVE STUDY; COMPETITIVE INHIBITION; CONTROLLED STUDY; DRUG ACTIVITY; DRUG POTENCY; DRUG RECEPTOR BINDING; ELECTRIC POTENTIAL; GLAUCOMA; ISOLATED RETINA; LABORATORY TEST; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; RADIOASSAY; RAT;

EID: 0034908480     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004170100312     Document Type: Article

References (61)

1. Sustained reduction of intraocular pressure in humans with the calcium channel blocker verapamil
2. Topical verapamil and episcleral venous pressure
3. Medical management of glaucoma
4. Effect of long-term topical betaxolol on tissue circulation in the iris and optic nerve head
5. The naming of voltage-gated calcium channels
6. The b-wave of the electroretinogram as an index of retinal ischemia
7. Delayed functional loss in glaucoma. LII Edward Jackson Memorial Lecture
8. Benzalkonium chloride and gentamicin cause a leak in corneal epithelial cell membrane
9. + channels: Comparison with other β-adrenoceptor antagonists
10. Glaucoma
11. Longterm effect of topical beta-blockers on intraocular pressure and visual field sensitivity in ocular hypertension and chronic open-angle glaucoma
12. Effect of the calcium antagonist, nifedipine, on ischemic retinal dysfunction
13. Distribution of betaxolol to posterior ocular tissues of the cynomolgus monkey following a 30-day BID topical ocular regimen of Betoptic S
14. A comparison of the effects of betaxolol, timolol, and pilocarpine on visual function in patients with open-angle glaucoma
15. A proposed role for excitotoxicity in glaucoma
16. 2+ channels in mammalian central neurons
17. 2+ currents in rabbit ciliary body epithelial cells
18. Prolonged adverse effects of benzalkonium chloride and sodium dodecyl sulfate in a primary culture system of rabbit corneal epithelial cells
19. Effects of betaxolol on light responses and membrane conductance in retinal ganglion cells
20. 2+ channels in skeletal muscle fibers by aminoglycoside antibiotics
21. The direct vascular relaxing action of betaxolol, carteolol and timolol in porcine long posterior ciliary artery
22. Suppressive actions of betaxolol on ionic currents in retinal ganglion cells may explain its neuro-protective effects
23. Ion channel components of retinal ganglion cells
24. Longterm visual field follow-up of glaucoma patients treated with beta-blockers
25. The changing landscape of ischaemic brain injury mechanisms
26. Dorzolamide effect on ocular blood flow
27. Reevaluating equilibrium and kinetic binding parameters for lipophilic drugs based on a structural model for drug interaction with biological membranes
28. 2+ of NMDA responses in spinal cord neurones
29. The effect of once-daily latanoprost on intraocular pressure and pulsatile ocular blood flow in normal tension glaucoma
30. The effect of topical diltiazem on the intraocular pressure in betamethasone-induced ocular hypertensive rabbits
31. 2+ channels
32. 1A receptor agonist 8-OH-DPAT: Possible significance for neuroprotection
33. Voltage-dependent calcium channels in the rat retina: Involvement in NMDA-stimulated influx of calcium
34. Stereospecificity of beta adrenergic antagonists: R-enantiomers show increased selectivity for beta-2 receptors in ciliary process
35. Color Doppler ultrasound analysis of ocular circulation after topical calcium channel blocker
36. Retinal ganglion cell death in glaucoma: The how, the why, and the maybe
37. In vivo and in vitro experiments show that betaxolol is a retinal neuroprotective agent
38. Topically applied betaxolol attenuates NMDA-induced toxicity to ganglion cells and the effects of ischaemia to the retina
39. Neuroprotection in relation to retinal ischemia and relevance to glaucoma
40. Ganglion cell death in glaucoma: What do we really know?
41. Block of P/Q-type calcium channels by therapeutic concentrations of aminoglycoside antibiotics
42. Number of people with glaucoma worldwide
43. Neuroprotection: Is it already applicable to glaucoma therapy?
44. A long-lasting hypotensive effect of topical diltiazem on the intraocular pressure in conscious rabbits
45. Dependence of photoreceptor glutamate release on a dihydropyridine-sensitive calcium channel
46. Neuroprotection: A new treatment modality for glaucoma
47. The topical application of verapamil and nifedipine lowers intraocular pressure in conscious rabbits
48. 1-selective adrenoceptor antagonist, on voltage-dependent calcium channels in guinea-pig artery and vein
49. Effect of calcium channel blockers alone and in combination with antiglaucoma medications on intraocular pressure in the primate eye
50. Characterization of the muscarinic receptor subtypes in the bovine corneal epithelial cells
51. 2+ channels in human and bovine trabecular meshwork cells
52. Molecular basis of glutamate toxicity in retinal ganglion cells
53. New approaches to antiglaucoma therapy
54. Regulation of transmitter release from retinal bipolar cells
55. Protective effects of flunarizine on ischemic injury in the rat retina
56. Effect of topical betaxolol on tissue circulation in the human optic nerve head
57. Effects of nilvadipine, a calcium antagonist, on rabbit ocular circulation and optic nerve head circulation in NTG subjects
58. 2+channel blocker, reduces glutamate-induced neurotoxicity and ischemia/reperfusion damage in rat retina
59. Plasma and aqueous humour concentrations and systemic effects of topical betaxolol and timolol in man
60. Topically applied betaxolol attenuates ischaemia-induced effects to the rat retina and stimulates BDNF mRNA
61. Comparison of short- and long-term effects of betaxolol and timolol on human retinal circulation